Live cell imaging of interleukin-6-induced targeting of "transcription factor" STAT3 to sequestering endosomes in the cytoplasm.
Signal transducer and activator of transcription (STAT) family transcription factors are classically viewed as transducing cytokine- and growth factor-activated signals from the plasma membrane to the cell nucleus for the purpose of activating transcription. We report live cell imaging studies of fluorescently labeled STAT3 expressed in Hep3B hepatocytes that reveal interleukin (IL)-6-activated targeting of STAT3 and PY-STAT3 to relatively long-lived sequestering endosomes in the cytoplasm. This targeting was rapid but transient, required phosphorylation and integrity of Tyr 705 in STAT3, and was blocked by nocodazole, geldanamycin, and indirubin E804 and by overexpression of wild-type caveolin-1. Strikingly, overexpression of the dominant-negative (DN) mutant K44A of the GTPase dynamin II led to marked constitutive accumulation of STAT3 in the endocytic compartment with depletion of the STAT3 nuclear pool. Subsets of the native and K44A-generated STAT3- and PY-STAT3-sequestering endosomes colocalized with MyD88, an adapter protein that integrates pathways of Toll-like receptor and IL-1 transcriptional signaling and stabilization of mRNAs. These data provide direct evidence for the cytokine-induced "signal transduction" by STAT3 from the plasma membrane to a cytoplasmic membrane destination for yet to be elucidated function(s) in the cytoplasm including prolongation of signaling and/or cross talk.
Xu
Fang
F
Department of Cell Biology & Anatomy, New York Medical College, Valhalla, NY 10595, USA.
Mukhopadhyay
Somshuvra
S
Sehgal
Pravin B
PB
D016227:Benzoquinones / Q000494:pharmacology; D015153:Blotting, Western; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000187:drug effects; D002467:Cell Nucleus / Q000378:metabolism; D003592:Cytophotometry; D003593:Cytoplasm / Q000187:drug effects / Q000378:metabolism; D034285:Dynamin II / Q000235:genetics / Q000378:metabolism; D011992:Endosomes / Q000378:metabolism*; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D022781:Hepatocytes / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D015850:Interleukin-6 / Q000494:pharmacology*; D047029:Lactams, Macrocyclic / Q000494:pharmacology; D008164:Luminescent Proteins / Q000235:genetics / Q000378:metabolism; D018613:Microscopy, Confocal; D009154:Mutation; D053594:Myeloid Differentiation Factor 88 / Q000378:metabolism; D015739:Nocodazole / Q000494:pharmacology; D010091:Oximes; D010766:Phosphorylation / Q000187:drug effects; D021381:Protein Transport / Q000187:drug effects; D050796:STAT3 Transcription Factor / Q000235:genetics / Q000378:metabolism*; D014162:Transfection
D016227:Benzoquinones; C509867:Indirubin E804; D007211:Indoles; D015850:Interleukin-6; D047029:Lactams, Macrocyclic; D008164:Luminescent Proteins; C507779:MYD88 protein, human; D053594:Myeloid Differentiation Factor 88; D010091:Oximes; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; D049452:Green Fluorescent Proteins; D034285:Dynamin II; D015739:Nocodazole; C001277:geldanamycin